These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6206518)

  • 1. Cardioprotective effects of enalapril in acute myocardial ischemia.
    Lefer AM; Peck RC
    Pharmacology; 1984; 29(2):61-9. PubMed ID: 6206518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of ibuprofen in acute myocardial ischemia.
    Lefer AM; Polansky EW
    Cardiology; 1979; 64(5):265-79. PubMed ID: 476733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    Brezinski ME; Darius H; Lefer AM
    Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vascular actions of the converting enzyme inhibitor, enalapril.
    Lefer DJ; Lefer AM
    Proc Soc Exp Biol Med; 1984 Feb; 175(2):211-4. PubMed ID: 6320208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the beneficial effect of dexamethasone on myocardial cell integrity in acure myocardial ischemia.
    Lefer AM; Crossley K; Grigonis G; Lefer DJ
    Basic Res Cardiol; 1980; 75(2):328-39. PubMed ID: 7396811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.
    Li K; Chen X
    J Mol Cell Cardiol; 1987 Sep; 19(9):909-15. PubMed ID: 2828645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
    Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
    [No Abstract]   [Full Text] [Related]  

  • 9. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction.
    Hock CE; Ribeiro LG; Lefer AM
    Am Heart J; 1985 Feb; 109(2):222-8. PubMed ID: 2981461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.
    Lefer AM; Polansky EW; Bianchi CP; Narayan S
    Basic Res Cardiol; 1979; 74(5):555-67. PubMed ID: 526260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia.
    Brezinski ME; Yanagisawa A; Lefer AM
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):65-71. PubMed ID: 2434797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
    Ogletree ML; Lefer AM; Smith JB; Nicolaou KC
    Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat.
    Spath JA; Lane DL; Lefer AM
    Circ Res; 1974 Jul; 35(1):44-51. PubMed ID: 4841252
    [No Abstract]   [Full Text] [Related]  

  • 14. Additive beneficial effects of two inhibitors of vasoconstrictor mediators in acute myocardial ischemia.
    Bitterman H; Lefer DJ; Lefer AM
    Proc Soc Exp Biol Med; 1987 Jul; 185(3):262-6. PubMed ID: 3037554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE; Lefer DJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a significant protective effect of augmented circulating glucose on the ischemic myocardium.BJ.
    Spath JA; Ogletree ML; Lefer AM
    Can J Physiol Pharmacol; 1976 Aug; 54(4):423-9. PubMed ID: 974870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two nonsulfhydryl angiotensin-converting enzyme inhibitors, CGS 14831 and CGS 16617, on myocardial damage and left-ventricular hypertrophy following coronary artery occlusion in the rat.
    Smith EF; Egan JW; Goodman FR; Zimmerman MB; Webb RL; Ribeiro LG
    Pharmacology; 1988; 37(4):254-63. PubMed ID: 2973611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
    Smith EF; Carrow BA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG; Hock CE; Edmonds JS; Lefer AM
    J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.